A new model of Hantaan virus persistence in mice: the balance between HTNV infection and CD8+ T-cell responses  by Araki, Koichi et al.
www.elsevier.com/locate/yviro
Virology 322 (2004) 318–327A new model of Hantaan virus persistence in mice: the balance between
HTNV infection and CD8+ T-cell responses
Koichi Araki,a Kumiko Yoshimatsu,b Byoung-Hee Lee,b Hiroaki Kariwa,a
Ikuo Takashima,a and Jiro Arikawab,*
aLaboratory of Public Health, Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University,
Sapporo 060-0818, Japan
b Institute for Animal Experimentation, Graduate School of Medicine, Hokkaido University, Sapporo 060-0863, JapanReceived 25 October 2003; returned to author for revision 10 December 2003; accepted 30 January 2004Abstract
We established a viral persistence model that involves the adoptive transfer of spleen cells from immunocompetent mice (H-2d) into
Hantaan virus (HTNV)-infected severe combined immunodeficient (SCID, H-2d) mice. The infection is maintained despite the presence of
neutralizing antibodies, without apparent signs of disease, and there is a correlation between HTNV persistence and the lack of HTNV-
specific CD8+ T cells. In addition, disseminated HTNV infection before the initiation of immune responses appears to be important for virus
persistence. The suppression of HTNV-specific CD8+ T cells in the present model appears to occur at the periphery. The present study also
demonstrates that CD8+ T cells contribute to the clearance of HTNV. Thus, it seems that HTNV-specific CD8+ T cells play a key role in
HTNV persistence in mice. This model of viral persistence is useful for studies of immune responses and immunocytotherapy against viral
infection.
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Hemorrhagic fever with renal syndrome (HFRS) and
hantavirus pulmonary syndrome (HPS) are rodent viral
zoonoses that are caused by viruses of the genus Hantavi-
rus, family Bunyaviridae (Schmaljohn and Hjelle, 1997).
At least 22 virus species have been identified (Elliott et al.,
2000), which are maintained by natural rodent reservoirs
despite the presence of neutralizing antibodies (Meyer and
Schmaljohn, 2000). In addition, persistent hantavirus infec-
tion in natural rodent reservoirs is established during
adulthood without any signs of disease (Meyer and
Schmaljohn, 2000). In addition, distinct hantaviruses are
associated with a single rodent species (Meyer and Schmal-
john, 2000).0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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host, which is Mus musculus (mouse). Although Hantaan
virus (HTNV), which is the prototype of the genus
Hantavirus, is maintained in the rodent species Apodemus
agrarius in nature (Meyer and Schmaljohn, 2000), it
produces a transient infection in adult mice and lethal
infection in newborn mice, following experimental infec-
tion. Therefore, studies on HTNV using experimental mice
have focused on vaccine development (Choi et al., 2003)
and the mechanism of viral pathogenicity (Ebihara et al.,
2000; Kikuchi et al., 1998; Kim and McKee, 1985; McKee
et al., 1985; Yoo et al., 1993). Previously, we established
persistent HTNV infection in newborn mice by inoculation
of a sublethal dose of HTNV within 24 h of birth (Araki et
al., 2003). These findings suggest that the persistently
HTNV-infected mouse has potential as a model of persis-
tent viral infections, such as those caused by the human
immunodeficiency virus, Epstein–Barr virus, and hepatitis
B and C viruses. Persistent HTNV infection in adult mice
that were infected as newborns was maintained despite the
presence of high-titer neutralizing antibodies (Araki et al.,
Fig. 2. Measurement of N protein levels in the organs of the HTNV-infected
SCID mice. Four SCID mice per group were inoculated intraperitoneally
with 2400 FFU HTNV. On days 7, 14, 21, 28, and 35 after virus infection,
the lungs, spleens, livers, kidneys, and brains were obtained from the
HTNV-infected SCID mice. The amount of N protein in each organ was
measured by Western blotting. Band density was determined by the NIH
Image 1.63 analysis software. To calculate the density of each point, the
average density of the lungs of the SCID mice at day 21 after virus infection
was set at 100%. The asterisks indicate that no band was detected. These
results were obtained in two independent experiments. The bars represent
the SD of the mean for each organ.
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evidence that CD8+ T cells contributed to the clearance of
HTNV in the previous study (Araki et al., 2003) due to
difficulties in modulating the immune responses of new-
born mice. Therefore, a more detailed investigation of the
mechanism of HTNV persistence requires a new model,
that is, one in which the immune responses can be readily
controlled and evaluated. In addition, the mouse model of
HTNV persistence should provide information regarding
the mechanism of persistent hantavirus infection in natural
rodent reservoirs.
The mechanism that has been advanced for persistent
lymphocytic choriomeningitis virus (LCMV) infection pro-
vides a useful platform for the evaluation of our model of
HTNV persistence because cytopathic effects are either
absent or incomplete in both LCMV- (Borrow and Old-
stone, 1997) and HTNV-infected cells (Pensiero et al.,
1992; Yanagihara and Silverman, 1990). In LCMV-
infected adult mice, high-level viral replication and dis-
seminated infection of the organs and tissues are important
for the establishment of persistent infection that is accom-
panied by the absence of virus-specific CD8+ T cells
(Borrow and Oldstone, 1997). Therefore, to establish the
new model of HTNV persistence, we hypothesized that
high-level HTNV replication and disseminated infection of
organs and tissues in mice might facilitate persistent
HTNV infection that is associated with the absence of
HTNV-specific CD8+ T cells.
In the present study, we investigated the above-described
hypothesis. We succeeded in establishing a new model of
viral persistence that involves the adoptive transfer of spleen
cells into severe combined immunodeficient (SCID) mice
14 days after HTNV infection. The mechanism of HTNV
persistence in these mice was examined and is the basis of
this report.Results
Adoptive transfer of spleen cells to HTNV-infected SCIDmice
Infection of adult SCID mice with HTNV leads to
disseminated infection. In efforts to investigate whether
disseminated HTNV infection before the induction ofFig. 1. Experimental design for the adoptive transfer of spleen cells. SCIDmice (H-2d
107 spleen cells from immunocompetent BALB/c mice (H-2d) at the indicated timeimmune responses affected persistent infection, we per-
formed the adoptive transfer of syngeneic adult immuno-
competent spleen cells to HTNV-infected SCID mice, as
illustrated in Fig. 1. First, we examined the spread of
HTNV infection in SCID mice before the adoptive transfer
of spleen cells by measuring the levels of N protein in
each organ (Fig. 2). On day 7 after virus infection, N
protein was detected only in the spleens. Disseminated
infection was observed in various organs (except for the
brain) on day 14 postinfection. On day 21 postinfection,
the N protein was detected in all of the tissues examined,
including the brain. The largest accumulation of N protein
was found in the lungs. We then carried out the adoptive
transfer of spleen cells from uninfected immunocompetent
BALB/c mice into HTNV-infected, MHC-identical SCID
mice (Table 1). These SCID mice, which were the recip-
ients of immunocompetent syngeneic spleen cells on days
0, 7, 14, and 21 after virus infection, all survived (Table
1). Although the SCID mice that received syngeneic cells) thatwere inoculated intraperitoneally with 2400FFUofHTNVreceived 2
s after virus infection. The condition of the SCID mice was observed.
Table 1
Adoptive transfer of spleen cells into SCID mice











+ + (day 0) 4/4  
+ + (day 7) 4/4  
+ + (day 14) 4/4  
+ + (day 21) 4/4  +
+ + (day 28) 2/4 44, 44 +
+ + (day 35) 0/4 41, 44, 46, 51 +
 + 4/4  
+  0/4 38, 44, 46, 46 +
a SCID mice (H-2d) were inoculated (+) intraperitoneally with HTNV (2400
FFU) or uninfected ().
b The SCID mice either received 2  107 spleen cells intraperitoneally from
immunocompetent (H-2d) mice (+) or did not undergo adoptive transfer
().
c Waddling gait and ruffled fur symptoms.
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symptoms, those that received cells on day 21 demonstrated
waddling gait and ruffled fur symptoms (Table 1). As
shown in Table 1, 2/4 mice that received syngeneic spleen
cells on day 28 and 4/4 mice that received syngeneic
spleen cells on day 35 died at various time points there-
after, which suggests that the adoptive transfer of spleen
cells by day 21 postinfection with HTNV is critical for
survival. The body weights of the SCID mice that received
spleen cells on days 0, 7, 14, and 21 postinfection were
measured and compared with those of the SCID controls
(no adoptive transfer after virus infection) (data not
shown). The body weights of the control mice decreased
from day 21 after virus infection. Mice that received
splenocytes on days 0 and 7 after virus infection showed
no decrease in body weight after adoptive transfer (data not
shown). Although the SCID mice that received spleen cells
on day 14 after virus infection showed some weight loss on
day 9 after adoptive transfer (data not shown), they
returned to their normal body weight shortly thereafter.
On the other hand, mice that received splenocytes on day
21 after virus infection showed marked body weight loss
and took a long time to return to normal body weight (data
not shown). In subsequent experiments, to investigate the
relationship between disseminated HTNV infection before
the induction of immune responses and HTNV persistence
in apparently asymptomatic SCID mice following adoptive
transfer of spleen cells, we used SCID mice into which
spleen cells had been transferred on days 0 and 14 after
virus infection.
HTNV-specific immune responses and N protein levels in
SCID mice that received spleen cells on days 0 and 14 after
virus infection
Previously, we established an assay for determining the
frequency of HTNV-specific CD8+ T cells using intracel-lular gamma interferon (IFN-g) detection (Araki et al.,
2003). Using this method, HTNV-specific CD8+ T-cell
responses were measured on day 30 post-transfer in SCID
mice that had received spleen cells by adoptive transfer on
days 0 and 14 after virus infection (Fig. 3A). All of the
mice that had undergone adoptive transfer on day 0 after
virus infection retained HTNV-specific CD8+ T cells (Fig.
3A, left panel). In contrast, HTNV-specific CD8+ T cells
were not detected in SCID mice that had undergone
adoptive transfer on day 14 after virus infection (Fig.
3A, right panel). These results suggest that disseminated
HTNV infection suppresses the induction of HTNV-spe-
cific CD8+ T cells. High neutralizing antibody titers were
observed in both groups (Fig. 3A). The levels of N protein
were measured in the lungs. Although N protein was not
detected in SCID mice that had undergone adoptive
transfer on day 0 after virus infection (Fig. 3A, left panel),
all of the mice that had undergone adoptive transfer on day
14 after virus infection carried N protein in their lungs
(Fig. 3A, right panel). Thus, SCID mice that had received
spleen cells on day 14 after virus infection showed
persistent infection despite the presence of neutralizing
antibodies. This SCID mouse model of persistent HTNV
infection suggests that the lack of HTNV-specific CD8+ T
cells is important for viral persistence. These data indicate
that persistent infection is possible in mice that display
disseminated HTNV infection before the induction of
immune responses.
Kinetics of HTNV-specific immune responses and the levels
of N protein in SCID mice that had received spleen cells by
adoptive transfer on day 14 after virus infection
We examined the kinetics of the HTNV-specific immune
responses and the levels of N protein in SCID mice that
had undergone adoptive transfer on day 14 after virus
infection (Fig. 3B). On day 60 after adoptive transfer, all
of the mice had N protein in their lungs and lacked HTNV-
specific CD8+ T cells (Fig. 3B, left panel). On day 90 after
adoptive transfer, HTNV-specific CD8+ T cells had
appeared in 1/4 of the mice, and this was accompanied
by low levels of N protein (Fig. 3B, center panel). On day
120 after adoptive transfer, the number of mice that had
HTNV-specific CD8+ T cells had increased, and these mice
had undetectable levels of N protein in their lungs (Fig. 3B,
right panel). However, even at day 120 after adoptive
transfer, 1/4 of the mice continued to have N protein in
the lungs and lacked HTNV-specific CD8+ T cells (Fig. 3B,
right panel). On the other hand, high neutralizing antibody
titers were observed in all of these mice (Fig. 3B). In
addition, we measured the tumor necrosis factor-alpha
(TNF-a) production of the IFN-g-producing cells upon
co-culture with HTNV-infected P388D1 cells. The
HTNV-specific CD8+ T-cell populations in the SCID mice
that had received spleen cells on days 0 and 14 after virus
infection contained a significant percentage (approximately
Fig. 3. Measurements of N protein levels in the lungs, neutralizing antibody titers (NT) in the sera, and IFN-g-producing, HTNV-specific CD8+ T-cell
responses in SCID mice, following adoptive transfer of spleen cells on days 0 or 14 after virus infection. SCID mice were inoculated intraperitoneally with
2400 FFU of HTNV. On days 0 or 14 postinfection (p.i.), 2  107 spleen cells from immunocompetent mice were adoptively transferred into the HTNV-
infected SCID mice. (A) On day 30 after the adoptive transfer, the lungs, sera, and spleens were removed from the SCID mice that received spleen cells on days
0 (A left) or 14 (A right) after virus infection. (B) On days 60 (B left), 90 (B center), and 120 (B right) after adoptive transfer, the lungs, sera, and spleens were
removed from the SCID mice that received spleen cells on day 14 after virus infection. The black bars represent the numbers of HTNV-specific CD8+ T cells
that produced IFN-g, and the white bars represent the levels of N protein. To detect HTNV-specific CD8+ T cells, spleen cells and HTNV-infected P388D1 cells
were co-cultured at a ratio of 1:0.5 in the presence of brefeldin A and IL-2. After a 6-h incubation, IFN-g-producing CD8+ T cells were detected by flow
cytometry. The data are shown as the number of IFN-g-producing HTNV-specific CD8+ T cells per spleen. No CD8+ IFN-g+ cells were detected from the
combination of spleen cells and uninfected P388D1 cells (data not shown). The values above the black bars are the percentages of IFN-g+ cells among CD8+ T
cells. The levels of N protein in the lungs were measured by Western blotting. The band densities were determined using the NIH Image 1.63 analysis software.
To calculate the density of each mouse lung, the average density of the HTNV-infected SCID mouse lung on day 21 after virus infection was set at 100%, as
described in the legend to Fig. 2. The asterisks indicate where no band was detected. FRNTs were carried out using sera. The neutralizing antibody titer is
expressed as the reciprocal of the highest serum dilution that resulted in a reduction of >80% in the number of infected cell foci. Uninfected SCID mice that
received spleen cells lacked HTNV-specific CD8+ T cells, N protein in the lungs, and neutralizing antibodies (data not shown). These results were obtained in
two independent experiments.
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Fig. 5. Detection of naı¨ve CD8+ T cells with specificity for HTNV. Nude
mice with either HTNV infection (2400 FFU) or mock infection received
2  107 spleen cells from immunocompetent mice on day 0 after virus
infection. On day 30 after adoptive transfer, spleen cells were removed from
the nude mice. The spleen cells and HTNV-infected P388D1 cells were co-
cultured at a ratio of 1:0.5 for 6 h in the presence of brefeldin A and IL-2.
IFN-g-producing, HTNV-specific CD8+ T cells were detected using flow
cytometry. The gates were set for spleen cells, and the values shown are the
percentages of IFN-g CD8+ and IFN-g+ CD8+ T cells. Data from a
K. Araki et al. / Virology 322 (2004) 318–3273224%) of IFN-g-producing cells, approximately 50% of
which also produced TNF-a (Fig. 4). Thus, the HTNV-
specific CD8+ T cells of SCID mice that had undergone
adoptive transfer on day 14 after virus infection were
similar, in terms of cytokine production, to those of SCID
mice that had undergone adoptive transfer on day 0 after
virus infection.
Detection of naı¨ve CD8+ T cells with specificity for HTNV
HTNV-specific CD8+ T cells were induced in SCID
mice within 30 days of the adoptive transfer of spleen cells
on day 0 postinfection (Fig. 3A, left panel). Knowledge
regarding the origin of these HTNV-specific CD8+ T cells
is important for a complete understanding of the mecha-
nism underlying the HTNV-specific CD8+ T-cell suppres-
sion that had been induced in SCID mice following
adoptive transfer on day 14 after virus infection. To
examine whether naı¨ve CD8+ T cells with specificity for
HTNV existed in the spleen cells used for adoptive transfer,
the spleen cells were transferred to HTNV-infected nude
mice that lacked the thymus (Fig. 5). HTNV-specific CD8+ T
cells were detected in these nude mice on day 30 after
adoptive transfer of the spleen cells. This result shows
that naı¨ve CD8+ T cells that are specific for HTNV exist
in the splenocytes that are used for adoptive transfer, and
that the origin of the HTNV-specific CD8+ T cells that are
induced in SCID mice following adoptive transfer at day
0 postinfection is constituted by naı¨ve CD8+ T cells with
specificity for HTNV. Furthermore, this result suggests
that the suppression of HTNV-specific CD8+ T cells seen
in SCID mice that had undergone adoptive transfer on
day 14 postinfection was caused at the periphery rather
than in the thymus because the thymus induces tolerance
during the maturation of pre-T cells, but not mature naı¨ve
T cells.Fig. 4. TNF-a production by IFN-g-producing CD8+ T cells in splenocytes obta
virus infection. The SCID mice were infected with HTNV (2400 FFU) and receiv
adoptive transfer, spleen cells were obtained from the SCID mice that were ado
transfer, spleen cells were obtained from the SCID mice that had undergone adop
were transferred into mock-infected SCID mice, and the spleen cells were remov
cells were tested for TNF-a production. To detect TNF-a+ CD8+ T cells, the sp
1:0.5 for 6 h in the presence of brefeldin A and IL-2. TNF-a production by CD8
CD8+ T cells, and the values shown are the percentages of TNF-a IFN-g+ cells
experiment are shown.CD8+ T cells contribute to HTNV clearance
The results obtained, to date, have shown a correlation
between HTNV persistence and the lack of HTNV-specific
CD8+ T cells (Fig. 3). To investigate whether CD8+ T cells
are required for HTNV clearance, spleen cells from HTNV-
immunized immunocompetent BALB/c mice were used for
the adoptive transfer (Fig. 6). These spleen cells included
many HTNV-specific CD8+ T cells (Fig. 6A). Whole spleen
cells or the CD8+ T-cell-depleted spleen cells were adop-
tively transferred to HTNV-infected SCID mice on day 14
after virus infection. N protein was absent from the lungs of
SCID mice that had been the recipients of whole spleen
cells, and numerous HTNV-specific CD8+ T cells were
detected (Figs. 6B, left panel, and C). In contrast, HTNV
persistence was observed in SCID mice that had been
representative experiment are shown.ined from the SCID mice that received spleen cells on days 0 or 14 after
ed 2  107 spleen cells on days 0 or 14 postinfection. On day 30 after the
ptively transferred on day 0 postinfection. On day 120 after the adoptive
tive transfer on day 14 postinfection. As the control, 2  107 spleen cells
ed from these mice on day 30 after the adoptive transfer. All of the spleen
leen cells and HTNV-infected P388D1 cells were co-cultured at a ratio of
+ IFN-g+ cells was detected using flow cytometry. The gates were set for
and TNF-a+ IFN-g+ cells among CD8+ T cells. Data from a representative
Fig. 6. The contribution of CD8+ T cells to HTNV clearance.
Immunocompetent BALB/c mice were inoculated intraperitoneally with
2400 FFU of HTNV. (A) On day 21 after virus infection, spleen cells were
removed from the immunocompetent mice. The spleen cells and HTNV-
infected P388D1 cells were co-cultured at a ratio of 1:0.5 for 6 h in the
presence of brefeldin A and IL-2. IFN-g-producing, HTNV-specific CD8+
T cells were detected using flow cytometry. The gates were set for spleen
cells, and the values shown are the percentages of IFN-g CD8+ and IFN-
g+ CD8+ T cells. (B and C) Whole spleen cells or CD8+ T-cell-depleted
spleen cells (>98% deletion) from the mice in (A) were transferred into
SCID mice on day 14 after virus infection. On day 30 after the adoptive
transfer, spleen cells and lungs were removed from the SCID mice. The
methods described above for (A) were also performed to detect HTNV-
specific CD8+ T cells (B). The levels of N protein in the lungs were
measured by Western blotting (C). Lane 1, molecular weight marker; lane 2,
following the transfer of whole spleen cells; lane 3, following the transfer of
CD8+ T-cell-depleted spleen cells. Data from a representative experiment
are shown.
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Although the recovery of just a few CD8+ T cells was
observed in the SCID mice that had received the CD8+ T-
cell-depleted spleen cells, there was a complete absence of
HTNV-specific CD8+ T cells in these mice (Fig. 6B, rightpanel). These data show that CD8+ T cells contribute to the
clearance of HTNV.Discussion
To establish a model of viral persistence in which
immune responses could be readily manipulated, we carried
out the adoptive transfer of spleen cells into HTNV-infected
SCID mice. Persistent HTNV infection was established in
SCID mice that had undergone adoptive transfer after
disseminated HTNV infection of various organs. This model
of viral persistence is characterized by high titers of neu-
tralizing antibodies, no detectable levels of HTNV-specific
CD8+ T cells, and no apparent signs of disease. These
results suggest that disseminated HTNV infection before
the induction of immune responses is important for the
establishment of persistent infection and for the suppression
of HTNV-specific CD8+ T cells in mice.
We further investigated whether the suppression of
HTNV-specific CD8+ T cells occurred in the periphery.
Generally, clonal T-cell deletion occurs in the thymus, and
there is also evidence for deletion or suppression in the
periphery. In the thymus, T cells with specificities for
ubiquitous self-antigens are deleted by negative selection
during the process of maturation of pre-T cells, which are
derived from hematopoietic stem cells (Anderson et al.,
1996; Zuniga-Pflucker and Lenardo, 1996). In contrast,
anergy or clonal deletion of naı¨ve T cells with specificities
for self-antigens that do not exist in the thymus take place
in the periphery. Nude mice, which lack the thymus, were
used to detect naı¨ve CD8+ T cells with specificity for
HTNV in the spleen cells that were used for adoptive
transfer. Because the thymus is required for the maturation
of pre-T cells that are derived from hematopoietic stem
cells, nude mice are unable to make T cells from hema-
topoietic stem cells or pre-T cells. The nude mice that
received spleen cells on day 0 after HTNV infection had
significant numbers of HTNV-specific CD8+ T cells (Fig.
5). Consequently, the origin of the HTNV-specific CD8+ T
cells that were induced in the nude mice was naı¨ve CD8+
T cells, and not hematopoietic stem cells. These findings
suggest that naı¨ve HTNV-specific CD8+ T cells existed in
the spleen cells used for adoptive transfer, and that these
T cells experienced anergy or clonal deletion in the
periphery of SCID mice that had undergone adoptive
transfer on day 14 after virus infection. These results also
suggest that it is possible to establish persistent HTNV
infection, not only in newborn mice that have immature
immune systems, as shown previously (Araki et al., 2003),
but also in adult mice that possess mature immune
systems.
In a previous study of HTNV-infected newborn mice
(Araki et al., 2003), we were unable to demonstrate con-
clusively that CD8+ T cells contributed to HTNV clearance
due to difficulties in modulating the immune responses of
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was observed in SCID mice that were recipients of CD8+ T-
cell-depleted syngeneic spleen cells, obtained from HTNV-
immunized immunocompetent mice. In contrast, SCID mice
that were recipients of unfractionated spleen cells from
HTNV-immunized mice showed an absence of detectable
N protein (Fig. 6). This demonstrates that CD8+ T cells
contribute to HTNV clearance. Additionally, it is known
that HTNV-specific CD8+ T cells are induced in both
HTNV-infected humans and mice (Araki et al., 2003; Park
et al., 2000; Van Epps et al., 1999), and that these infections
are transient. In addition, hantavirus-specific CD8+ T cells
have been observed in other transient hantavirus (Puumala
virus and Sin Nombre virus) infections of humans (Ennis et
al., 1997; Van Epps et al., 2002). Taken together, it seems
that CD8+ T cells are required for the clearance of hantavi-
ruses. These results also suggest that persistent hantavirus
infections in natural rodent reservoirs are due to escape from
CD8+ T cell immune surveillance, although it is unclear how
hantaviruses escape the hantavirus-specific CD8+ T cells in
natural rodent reservoirs.
In addition to the mechanism of HTNV clearance, the
mechanism of HTNV persistence is a key issue in this
mouse model. HTNV-infected SCID mice that did not
receive syngeneic spleen cells died from the infection, and
HTNV persistence was established in HTNV-infected SCID
mice that received CD8+ T-cell-depleted syngeneic spleen
cells from HTNV-immunized immunocompetent BALB/c
mice. These results indicate that CD4+ T cells and B cells
contribute to viral persistence in the absence of any signs of
disease.
However, B cells seem to be more important than CD4+
T cells for HTNV persistence in mice. Nude mice showed
asymptomatic viral persistence when infected intraperito-
neally with HTNV (K. Yoshimatsu, and J. Arikawa, unpub-
lished data). The persistently HTNV-infected nude mice had
low titers of HTNV-specific antibodies. These results sug-
gest that the B cells and low-titer antibodies that are induced
without CD4+ T-cell help are important for HTNV persis-
tence in mice. CD4+ T cells may simply play a supporting
role in the production of high-titer antibodies that are
specific for HTNV.
Moreover, it seems that the role of HTNV-specific
antibodies that are produced by the B cells in persistently
HTNV-infected mice is to evade fatal disease. Generally,
the high-level growth of HTNV in the brain is important in
producing the fatal outcome in mice (Ebihara et al., 2000;
Kurata et al., 1983; McKee et al., 1985). The passive
transfer of HTNV-specific antibodies into infected mice
confers protection against lethal infection (Arikawa et al.,
1992; Yoshimatsu et al., 1993). Therefore, antibodies are
important for the suppression of HTNV growth in the
brain and in the evasion of fatal illness. These findings
suggest that HTNV-specific antibodies are necessary for
HTNV persistence in the absence of morbidity. Thus, the
existence of B cells is essential for the establishment ofpersistent HTNV infection without any signs of disease in
mice.
Additionally, NK cells are known to contribute to innate
defense against viral and bacterial infections. SCID mice
have mature NK cells that are phenotypically and function-
ally indistinguishable from NK cells found in immunocom-
petent mice (Kumar et al., 1989). However, because the
HTNV-infected SCID mice died from the infection, it is
clear that NK cells alone are not sufficient to confer
protective immunity against HTNV infection. However, it
remains unclear whether NK cells act cooperatively with
other components of the immune system to generate pro-
tective immunity.
The present model of viral persistence is similar, in
terms of the presence of neutralizing antibodies and the
lack of apparent signs of disease, to natural rodent reser-
voirs that are persistently infected with hantaviruses (Meyer
and Schmaljohn, 2000). Although it is believed that per-
sistent hantavirus infection in natural rodent reservoirs is
life-long (Meyer and Schmaljohn, 2000), HTNV was
eliminated by day 120 post-transfer from most of the SCID
mice that had undergone adoptive transfer on day 14 after
virus infection. In this respect, it appears that the present
model does not reflect, completely, the natural rodent
reservoir. Therefore, comparisons of the HTNV-specific
T-cell responses between the present model and the natural
rodent reservoir need to be made within the context of
these findings, and the results should be important with
regard to understanding persistent hantavirus infection in
nature. However, this type of comparison is difficult
because, to the best of our knowledge, there have been
no reports on the T-cell responses in hantavirus-infected
natural rodent reservoirs. To further investigate the mech-
anism of persistent hantavirus infection in natural rodent
reservoirs, the establishment of a method for measuring
hantavirus-specific CD8+ T cells in natural rodent reser-
voirs is required.
When the spleen cells were adoptively transferred into
HTNV-infected SCID mice on day 21 after virus infection,
an exacerbation of disease symptoms was observed, as
compared to HTNV-infected SCID mice that did not under-
go adoptive transfer. Previously, we showed an increase in
the serum BUN levels of HTNV-infected SCID mice
following adoptive transfer (Yoshimatsu et al., 1997). These
results suggest that immune system-mediated pathogenicity
occurred in these mice. In addition, both HFRS and HPS
patients demonstrate varying degrees of pathology that are
thought to be immune-related because hantaviruses infect
endothelial cells without direct cytopathic effects (Pensiero
et al., 1992; Sundstrom et al., 2001; Zaki et al., 1995), and
this is accompanied by marked increases in both CD8+ T-
cell numbers and in the levels of inflammatory cytokines,
such as IFN-g, TNF-a, and IL-6 (Chen and Yang, 1990;
Huang et al., 1994; Krakauer et al., 1994; Linderholm et al.,
1996; Markotic et al., 1999; Temonen et al., 1996). There-
fore, the adoptive transfer on day 21 after virus infection of
K. Araki et al. / Virology 322 (2004) 318–327 325SCID mice may have potential as a model of HFRS and
HPS.
In summary, we have established a model of viral
persistence using SCID mice and HTNV. It seems that
disseminated HTNV infection before the induction of
immune responses plays a key role in the persistent
infection and suppression of the generation of HTNV-
specific CD8+ T cells from the naı¨ve CD8+ T cells of
mice. Furthermore, we have demonstrated that CD8+ T
cells contribute to HTNV clearance. The present model of
viral persistence is useful for studies of immune responses
and of immunocytotherapy against viral infection because
the induction of immune responses, and the types of
immunocytes used for adoptive transfer, can be readily
manipulated.Materials and methods
Mice
Six-week-old BALB/c mice (H-2d) and six-week-old
BALB/c-nu/nu mice (nude mice, H-2d) were obtained from
SLC (Hamamatsu, Japan). Six-week-old CB-17/Lcr-scid Jcl
mice (SCID mice, H-2d) were obtained from CLEA Japan
(Tokyo, Japan). All of the mice were treated according to
the laboratory animal control guidelines of our institute,
which conform to those of the U.S. National Institute of
Health. All of the experiments were carried out in a class P3
facility.
Viral infection of mice
HTNV cl-1 (Ebihara et al., 2000) was obtained by plaque
cloning of HTNV strain 76-118. The virus was propagated
in the E6 Vero cell clone (Vero E6), which was grown in
Eagle’s minimal essential medium (EMEM; Invitrogen) that
was supplemented with 5% fetal bovine serum (FBS). Six-
week-old adult BALB/c, nude, and SCID mice were inoc-
ulated intraperitoneally with 2400 focus-forming units
(FFU) of HTNV.
Cell preparations
Single-cell suspensions of spleen cells were obtained by
homogenizing spleens through a mesh. The erythrocytes
were lysed with 0.83% NH4Cl. For the adoptive transfer
experiments, the spleen cells were suspended in RPMI 1640
medium (Invitrogen) that was supplemented with 10% FBS
and 50 AM 2-mercaptoethanol (ME) and incubated in a 150-
cm2 cell culture flask for 2 h at 37 jC in 5% CO2 to remove
adherent cells. To deplete the CD8+ T cells, the spleen cells
(1  107 cells/ml) were treated with the rat anti-mouse CD8
monoclonal antibody (mAb, 1 Ag/ml; Serotec) or rat IgG
(isotype control, 1 Ag/ml; Serotec) for 1 h on ice, and then
incubated in a 1:10 dilution of rabbit complement (Low-Tox-M; Cederlane Laboratories, Hornby, ON, Canada) for 1 h at
37 jC. Flow cytometric analysis was performed to determine
the efficacy of the procedure; >98% of the CD8+ T-cell
subpopulation was depleted.
Adoptive transfer of spleen cells into SCID or nude mice
Spleen cells were obtained from naı¨ve BALB/c mice or
HTNV-infected BALB/c mice, 21 days after infection. The
SCID and nude mice received either 2  107 spleen cells or
1.7  107 CD8+ T-cell-depleted spleen cells by intraperito-
neal injection.
Clinical features of the mice
Waddling gait, ruffled fur, weight loss, and mortality
were used to evaluate the clinical severity of HTNV
infection.
Fluorescence staining and flow cytometry
To detect HTNV-specific CD8+ T cells, we used flow
cytometry to assay the intracellular cytokines of CD8+ T
cells that were stimulated by HTNV-infected antigen-pre-
senting cells, as described previously (Araki et al., 2003).
Briefly, spleen cells were added to 96-well round-bottomed
plates at a concentration of 5  105 cells/well in RPMI
1640 medium that was supplemented with 10% FBS, 50
AM 2-ME, 20 U/ml recombinant interleukin (IL)-2 (Sigma
Co., St. Louis, MO), and 10 Ag/ml brefeldin A (Sigma),
along with the HTNV-infected or noninfected P388D1
cells at a concentration of 2.5  105 cells/well. After a
6-h incubation, the cells were stained with Tri-color (TC)-
conjugated rat anti-mouse CD8a (Ly-2) mAb (Caltag
Laboratories, San Francisco, CA) for 30 min on ice, then
fixed and permeabilized with saponin (Sigma), before the
addition of the fluorescein isothiocyanate-conjugated rat
anti-mouse IFN-g mAb (Caltag Laboratories) and the R-
phycoerythrin-conjugated rat anti-mouse TNF-a mAb
(Caltag Laboratories). The cell samples were analyzed
using the FACSCalibur system (Becton Dickinson), and
the data analyses were conducted with CellQuest (Becton
Dickinson).
Western blotting for the detection of N protein in lung, liver,
spleen, kidney, and brain tissues of HTNV-infected mice
Western blotting was performed using previously pub-
lished methods (Yoshimatsu et al., 1995). Briefly, 20 Al of
10% tissue homogenate was used as the antigen. Polyclonal
rabbit anti-N protein antibody (diluted 1:800 with PBS)
(Araki et al., 2001), which was prepared by immunizing a
rabbit with the truncated N protein expressed in E. coli, was
used to detect the N protein on the membrane. Horseradish
peroxidase-conjugated goat anti-rabbit IgG (1:500, Jackson
ImmunoResearch, West Grove, PA) was used as the sec-
K. Araki et al. / Virology 322 (2004) 318–327326ondary antibody. Western blotting was quantified by den-
sitometry with the NIH Image v. 1.63 analysis software.
NIH Image was developed at the National Institute of
Health and is available on the Internet (http://rsb.info.nih.
gov/nih-image/).
Focus reduction neutralization test
Focus reduction neutralization tests (FRNTs) were per-
formed using the previously published method (Araki et al.,
2001). Briefly, 100 Al of serial 4-fold dilutions of serum that
had been heat-inactivated for 30 min at 56 jC were mixed
with equal volumes of virus suspensions that contained 400
FFU of HTNV and incubated at 37 jC for 1 h. Then, 50-
Al aliquots of the mixture were inoculated onto Vero E6 cell
monolayers in 96-well plates and incubated at 37 jC for 1 h in
a 5% CO2 incubator. After adsorption for 1 h, the wells were
overlaid with EMEM that contained 1.5% carboxymethyl
cellulose. The plates were incubated for 7 days, and the
monolayers were fixed with acetone/methanol (1:1) and
dried. For the detection of virus foci, the polyclonal rabbit
anti-N protein antibody was added to the 96-well plate. The
plate was incubated for 1 h at 37 jC, washed with PBS, and
then incubated with horseradish peroxidase-conjugated goat
anti-rabbit IgG (1:500; Jackson ImmunoResearch) for 1 h at
37 jC. The plate was washed with PBS, and the viral foci
were stained with the 3-amino-9-ethylcarbazole substrate
(Sigma), according to the manufacturer’s instructions.Acknowledgments
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